SCHEMBL1670905

SCHEMBL1670905

CN1CCC(c2cc(CCOCCC(=O)O)ccc2O)CC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NUDT1 P36639 1/20 0.42
▸ BACE1 P56817 1/20 0.42
▸ QDPR P09417 2/20 0.40
▸ THRB P10828 3/20 0.39
▸ THRA P10827 2/20 0.39
▸ APP P05067 2/20 0.39
▸ PKM P14618 1/20 0.38
▸ CHRM5 P08912 2/20 0.37
▸ CHRM1 P11229 2/20 0.37
▸ CHRM3 P20309 2/20 0.37
▸ MAPT P10636 1/20 0.36
▸ BLM P54132 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ HTR1D P28221 1/20 0.36
▸ HTR1B P28222 1/20 0.36
▸ S1PR1 P21453 1/20 0.36
▸ FFAR4 Q5NUL3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1668329 0.90 NUDT1 (0.40) NUDT1BACE1THRBTHRAAPP
SCHEMBL1668679 0.88 APP (0.40) NUDT1BACE1THRBTHRAAPP
SCHEMBL12801311 0.76 NUDT1 (0.43) NUDT1BACE1THRBTHRAAPP
SCHEMBL16499437 0.76 BACE1 (0.71) NUDT1BACE1QDPRMAPTBLM
SCHEMBL12801191 0.75 CHRM5 (0.46) APPCHRM5CHRM1CHRM3
SCHEMBL1668475 0.73 FFAR4 (0.47) APPCHRM5CHRM1CHRM3S1PR1
SCHEMBL7794845 0.73 NUDT1 (0.67) NUDT1BACE1THRBTHRAS1PR1
SCHEMBL16499122 0.71 ALDH1A1 (0.44) NUDT1BACE1QDPRTHRBTHRA
SCHEMBL12800404 0.71 CHRM5 (0.40) APPCHRM5CHRM1CHRM3S1PR1
SCHEMBL1668720 0.71 CHRM5 (0.43) CHRM5CHRM1CHRM3S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011048409-A1 CYCLIC AMINE DERIVATIVES HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY ASTRAZENECA AB (SE) 2011-04-28 — — WO disclosed
Send feedback